Sentence examples for trial in comparison with the from inspiring English sources

In contrast with the earlier studies, the experience from the EPHT trial did not show an exaggerated treatment effect within the non-blind trial in comparison with the blind trial [ 26, 27].

The correct responses on selective attention were higher in the Val/Val group, and the number of errors committed was higher in the Met/Met group during the incongruence trial in comparison with the Val/Val group.

The inconsistent effect of hormone therapy on painful intercourse during the EPHT Trial could be explained by lower adherence rates at the end of the trial in comparison with the adherence rates in hormone therapy arms at the end of the first trial year.

If restricting the analysis with the year 2004 when unblinding occurred after stopping trial treatment, there were less cancer cases (HR 0.53; 95% CI: 0.31-0.91), less cerebrovascular disease events (HR 0.57; 95% CI: 0.38-0.84) and fewer outcomes combined (HR 0.78; 95% CI: 0.66-0.91) among women recruited to the blind trial in comparison with those recruited to the non-blind trial.

The platinum-free interval and single maximum dose of >650 mg on the current trial were analysed only in the patients who developed HSR on trial in comparison with those with no history of HSR.

Figure 7 shows the RMSE obtained after the 5th trial, 25th trial and 50th trial models in comparison with the initial model.

30 The other effectiveness measurements were the change in the Spanish version of the HAM-A scale, 27 such as response rate (percentage of patients with a reduction ≥ 50% at end-of-trial in comparison with the baseline intensity of anxiety symptoms assessed using the HAM-A scale) and percentage of subjects without anxiety symptoms at end-of-trial (HAM-A ≤ 9 points).

According to the above, the culture condition of 1% FBS in GRACE's medium was chosen to continue with the trials in comparison with the standard growing condition (10% FBS in GRACE's medium).

The functional immunogenicity of PCV13 in individuals ≥50 years of age has been demonstrated in clinical trials in comparison with the 23-valent pneumococcal polysaccharide vaccine and for children and adults 6 to 49 years of age.

First, a fairly high proportion of women declared that they had consulted the results of the trial in comparison with what health professionals' statements might suggest (Partridge et al, 2004).

However, sheep that were treated with a topical application of potassium permanganate solution were significantly less likely to recover (less than 50% sheep recovered in the trial) in comparison with injectable antibacterials (χ2 = 24.29, p < 0.001; Figure 1; Table 2).